In fact, MEF2C was proposed to promote metastases development in pancreatic adenocarcinoma by inducing metalloproteinase (MMP) 10 transcription [30] and to promote myeloid leukaemia, behaving as an oncogene by cooperating with the Sox4 gene [31]. This evidence concerns the gene SOX4 and pancreatic adenocarcinoma.